Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,266 | -28,304 | -15,827 | -50,171 | -36,969 |
| Depreciation Amortization | -542 | -422 | -204 | -64 | -42 |
| Accounts payable and accrued liabilities | 3,531 | 1,142 | 1,226 | 364 | -561 |
| Other Working Capital | 6,553 | 4,214 | 3,969 | 111 | -1,405 |
| Other Operating Activity | 3,472 | 3,640 | 1,236 | 7,819 | 6,835 |
| Operating Cash Flow | $-29,251 | $-19,730 | $-9,601 | $-41,942 | $-32,142 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,398 | -3,185 | -10,551 | 69,490 | 96,917 |
| Investing Cash Flow | $16,398 | $-3,185 | $-10,551 | $69,490 | $96,917 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -4,001 | -4,001 |
| Common Stock Issued | 525 | 525 | 525 | 656 | 491 |
| Financing Cash Flow | $525 | $525 | $525 | $-3,345 | $-3,510 |
| Beginning Cash Position | 50,335 | 50,335 | 50,335 | 26,132 | 26,132 |
| End Cash Position | 38,006 | 27,945 | 30,708 | 50,335 | 87,397 |
| Net Cash Flow | $-12,329 | $-22,390 | $-19,627 | $24,203 | $61,265 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,251 | -19,730 | -9,601 | -41,942 | -32,142 |
| Free Cash Flow | -29,251 | -19,730 | -9,601 | -41,942 | -32,142 |